We’re proud to share that Abeona has received a PM360 Magazine Trailblazer Award in the Most Innovative New Product category for our FDA-approved gene therapy for the #RDEB community. Thank you to our team and the patients, caregivers and advocates who inspire us.

We congratulate @ultragenyx on the U.S. FDA approval of a gene therapy for patients with Sanfilippo syndrome type A (MPS IIIA). We are proud to have contributed to the program’s early development and celebrate this milestone for patients and families: bit.ly/3Tf8U1b

Expanding access to specialized care for the recessive dystrophic epidermolysis bullosa (#RDEB) community. Abeona activates the newest Qualified Treatment Center for the administration of our first and only autologous cell-based gene therapy. Learn more: bit.ly/4xZMxMA

Our cell-based gene therapy for recessive dystrophic epidermolysis bullosa (RDEB) is a finalist in the @PM360online Trailblazer Awards for Most Innovative New Product and Product Launch of the Year. A recognition of the innovation driving our work to advance genetic medicine.

Abeona is participating in several upcoming investor conferences: 📍@Official_Cantor Global Healthcare Conference 2026 📍@HCWCO 28th Annual Global Investment Conference 📍@MorganStanley 24th Annual Global Healthcare Conference Access webcasts and replays: bit.ly/3SGlGWs

#NEWS: Today, we reported our Q2 2026 financial results. Read more: bit.ly/3S2rKrZ #Investors #Earnings $ABEO

We were excited to be on the ground at the 2026 @debraOfAmerica Care Conference with the #EpidermolysisBulloa community who are working together to advance care and innovation. #debraCareConference

What can one of the most fragile conditions teach us about the future of medicine? Abeona CEO & Director Vishwas Seshadri shares how recessive dystrophic epidermolysis bullosa (#RDEB) is shaping scalable gene and cell therapies: bit.ly/4fWzrJO #MedEd #RareDisease

Abeona Therapeutics is attending #BIO2026! Joe Fogerty and Mohamad Tabrizi will be on site connecting with global leaders and partners advancing innovation and collaboration. If you’re heading to San Diego, connect with our team!

#NEWS: Today, we reported our Q1 2026 results and pipeline updates. Learn more: bit.ly/4tkiE6m #Investors #Earnings $ABEO

We look forward to connecting with researchers, clinicians and industry peers at the @SocInvestDerm Annual Meeting. Join us for our two poster presentations on May 14 and May 15 from 4:30–6:00 PM CT. #SID2026 #Dermatology #RareDisease #GeneTherapy #ClinicalResearch #MedEd

We are proud to welcome Gianine Esposito as Chief People Officer. With 25+ years of HR leadership experience, Gianine brings a proven ability to align talent, culture and strategy to drive growth at Abeona. Read more: bit.ly/488ujh4

We’re excited to support and participate in the @plungeforelodie with @EBResearch. On April 8, our Cleveland team hosted a dunk tank as part of our ongoing sponsorship and commitment to raise awareness and funds for epidermolysis bullosa research.

Welcome, @keithgoldan to our Board of Directors! “I am excited to join the Board of Directors at Abeona at this important time in the organization’s growth as commercial momentum continues to build for its first US launch,” said Mr. Goldan. Read more: bit.ly/4csA37E

New in NY: We have announced a Qualified Treatment Center providing access to our first-of-its-kind, FDA-approved gene therapy for the #RDEB community. Read more: bit.ly/AbeonaNYCQTC #MedEd

#NEWS: Abeona Therapeutics shared our Q4 and FY 2025 financial results and corporate updates. Listen to the highlights: bit.ly/475GmuY #Investors #Earnings $ABEO

Abeona Therapeutics is live at @LeerinkPartners Global Healthcare Conference 2026! Tune in to the fireside chat: bit.ly/4ukx8F1 $ABEO

This #InternationalWomensDay, we celebrate the incredible women whose leadership and dedication drive our mission forward. Thank you for making a meaningful impact every day. #IWD2026 #TeamAbeona

Today, we celebrate the employees who make our mission possible. Thank you for advancing cell and gene therapies for people impacted by serious diseases. #EmployeeAppreciationDay #TeamAbeona

On Tuesday, March 17, join our conference call where we will discuss our Q4 and full year 2025 financial results and corporate progress. Learn more: bit.ly/3MDymug $ABEO